Slides
Page 1
Weave Overview Q2 2026 NYSE : WEAV C weave
Page 2
2 This presentation has been prepared by Weave Communications, Inc. (“Weave”, “we”, “us”, or “our”) for informational purposes only and not for any other purpose. This presentation contains “forward-looking statements” within the Private Securities Litigation Reform Act of 1995 that are based on our management’s current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs and on information currently available to management. Forward-looking statements include all statements other than statements of historical fact contained in this presentation, including statements regarding information or predictions concerning our future financial performance, strategies, business plans and objectives, long-term target model, potential market and growth opportunities, competitive position, technological or market trends and industry environment. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “objective,” “ongoing,” “plan,” “predict,” “project,” “potential,” “should,” “will,” “would” or the negative of these terms or other comparable terminology. Forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results or outcomes to be materially different from any future results or outcomes expressed or implied by the forward-looking statements including, but not limited to, those related to our business and financial performance, our ability to attract and retain talent, leadership changes, our ability to attract and retain customers, our focus on serving small businesses, our ability to develop new products and enhance our platform and products, our ability to respond rapidly to emerging technology trends including those related to artificial intelligence, our ability to execute on our business strategy, our ability to compete effectively and our ability to manage growth. Moreover, we operate in a very competitive and rapidly changing environment in which new risks may emerge from time to time. It is not possible for us to predict all risks nor can we assess the impact of all factors on our business or the extent to which any factor, or the combination of factors, may cause our actual results or performance to differ materially from those contained in any forward-looking statements we may make. These factors, together with those described in greater detail in our Quarterly Report on Form 10-Q that we filed with the Securities and Exchange Commission (“SEC”) on August 6, 2026, may cause our actual results, performance or achievements to differ materially and adversely from those anticipated or implied by our forward-looking statements. All forward-looking statements herein reflect our opinions only as of the date of this presentation, and we undertake no obligation, and expressly disclaim any obligation, to update forward-looking statements herein in light of new information or future events, except to the extent required by law. This presentation contains statistical data, estimates and forecasts that are based on independent industry publications or other publicly available information, as well as other information based on our internal sources. This information involves many assumptions and limitations, and you are cautioned not to give undue weight to these estimates. Although we believe such information is accurate and that the sources from which it has been obtained are reliable, we have not independently verified the accuracy or completeness of the data contained in these industry publications and other publicly available information. Accordingly, we make no representations as to the accuracy or completeness of that data nor do we undertake to update such data after the date of this presentation. This presentation includes non-GAAP financial measures, including free cash flow and adjusted loss from operations. These non-GAAP financial measures are in addition to, and not as a substitute for or superior to measures of financial performance prepared in accordance with GAAP . There are a number of limitations related to the use of these non-GAAP financial measures. For example, other companies may calculate similarly-titled non-GAAP financial measures differently. Refer to the Appendix for a reconciliation of these Non-GAAP financial measures to the most directly comparable GAAP measures. Safe Harbor Statement
Page 3
3 Elevate the patient experience through a unified platform that improves business operations so healthcare professionals can focus on patient care and realize their dreams. Our vision 3 Q2 2026
Page 4
4 A better healthcare experience. Every practice. Every patient. Every interaction. Who we are Leading vertical SaaS company that delivers AI-powered patient engagement and payment solutions for healthcare practices. What we do Help practices grow, keep schedules full, optimize operations, get paid faster, and elevate patient experiences. FY’25 Total Revenue 17% YoY Growth $239M 40,000+Customer locations Q2 2026
Page 5
5 Q2 2026 Financial Update $67.5MTotal Revenue 15.5% YoY Growth 89%Gross Revenue Retention Rate $204MTTM Q1’25 Subscription & Payment Processing Revenue 20% YoY Growth $3.2MNon-GAAP Operating Income $3.1M YoY Increase $49.0MNon-GAAP Gross Profit 16.0% YoY Increase 5 72.6%Non-GAAP Gross Margin 30 bps Improvement YoY Q2 2026 $8.7MFree Cash Flow $4.2M YoY Increase
Page 6
6 Investor highlights Q2 2026 Solving customer challenges Large and growing TAM Multiple growth vectors Industry leading AI-powered platform Improving financial profile 21 345
Page 7
7 Q2 2026 Our customer’s main challenges Keeping schedules and chairs full Patient churn, missed calls, and no-shows leave revenue on the table. Practices spend heavily to acquire patients but lack the tools to retain and recall them consistently. Staffing shortages and cost inflation A national shortage of qualified front-desk staff, combined with rising wages and declining reimbursements means practices are doing more with less and staff burnout is real. Revenue leaks at every step Missed co-pays, denied claims, manual billing, unpaid balances, and slow collections create cash flow pressure that compounds over time.
Page 8
8 01 Automated responses ensure no call or text goes unanswered Recall and reactivation campaigns re-engage lapsed patients Wait List workflows automatically fill last-minute cancellations, Smart reminder workflows reduce forgotten and missed appointments. AI Receptionist allows patients to book, confirm, cancel, or reschedule by voice or text 24/7. Helps keep schedules full 02 Consolidates calls and messages into a single unified inbox 24/7 coverage, eliminating backlogs of missed calls and voicemails. Automates pre-appointment insurance verification and eligibility checks, cutting down time spent on hold with payors. Automates manual tasks 03 Confirms insurance eligibility and collects co-pays up front via card on file or text-to-pay, Sends automated Text-to-Pay links from the practice's trusted number. In-house or third-party payment plans give patients flexible financing options to accept treatment. Automates follow-up reminders on small unpaid balances after the appointment, so they don't linger or get deprioritized. Helps plug revenue leaks How Weave solves customer challenges
Page 9
9 Practices have to manage a patchwork of point solutions Running a healthcare business means deploying, managing, and paying for a patchwork of point solutions, often without dedicated IT, business intelligence, finance, or marketing teams 8x8 RingCentral Spectrum Comcast Business Zipwhip Twilio BirdEye Podium GatherUp Square Clover Jotform Zoho Vagaro Setmore Mailchimp Klaviyo HubSpot Reviews SchedulingPayments Phones Forms Messaging Email Q2 2026
Page 10
10 With over 150 integrations, including the industry’s biggest names, we can work with almost any customer’s preferred system of record. Authorized integrations. More customer value. Q2 2026
Page 11
11 Weave TAM Opportunity in DOV Historical focus has been Dental, Optometry, and Veterinary verticals. Significant opportunity remains to grow within our current TAM. International Target Markets (DOVM) Further expanding TAM Significant opportunity to expand TAM within medical verticals beyond Weave’s current focus markets. DOV + All Medical (US) $0.25B2Weave trailing 12-month revenue $3B3 $10B3 $22B1,4 Future TAM opportunity Target international healthcare SMBs. DOV (US) Growing opportunity in current TAM Weave's near-term focus is expanding into specialty medical verticals, including Physical Therapy, MedSpa, Plastic Surgery, and Primary Care. $5B3 1. Estimated total locations of 2.3 million, multiplied by * total ARR (subscription + payments + TrueLark) per location 2. Trailing twelve months of revenue, Q2'25 through Q1'26 3. Sources used to derive TAM for each vertical include IBIS, BLS, Census, industry-specific organizations (such as the American Dental Association, American Optometric Association, American Veterinary Medical Association, etc), market research reports, and proprietary Weave data 4. International TAM consists of locations within 17 target countries (Australia, New Zealand, Canada, UK, Ireland, Germany, Austria, France, Netherlands, Belgium, Switzerland, Norway, Sweden, Denmark, Finland, Czechia, and Singapore); TAM estimates derived from Passport by Euromonitor labor statistics within each vertical DOV + Select Med (US)
Page 12
12 Our growth vectors Q2 2026 Specialty medical verticals Integration partnerships Payments Multi-location practices AI-powered innovations
Page 13
13 Weave: Purpose-built for the healthcare journeyWeave owns the full telephony stack, executing workflows natively through the trusted business phone number Pre-care Acquisition and re-engagement The Funnel: Intake Admin automation Clinical visit Financial solutions Post-treatment Reputation and A/R Q2 2026
Page 14
14 Weave is the system of action for the healthcare front office Creating a differentiated ability to act Owns the patient conversation layer Every practice workflow initiates or terminates within Weave's communications rails. Omnichannel context in a single platform Phones, messages, payments and additional context from integrated systems inform intelligent patient interaction. Verticalized data flywheel compounds the AI advantage Over a billion interactions — irreplicable advantage over point solutions that enables intelligent workflow orchestration. Extensibility and flexibility PMS-agnostic with a broad, authorized catalog of industry-specific integrations. Enterprise-grade trust & compliance HIPAA, PCI, 10DLC, TCPA — purpose-built for regulated healthcare workflows at scale. Omnichannel Patient Engagement 360° Patient View Federated Reasoning & Orchestration First-Party Structured & Unstructured Data Voice Text Email Fax Payments Phone Hardware & Primary Business Number Structured Data PMS Authorized HIPAA-compliant integrations EHR System-of-record integration path RCM Payment workflows & requests Weave OwnedDeeply Integrated
Page 15
15 Q2 2026 Product platform Core Communications Includes Call Pop, Two-way Texting, and Text to Pay. Scheduling Automations Includes Appointment Reminders and Online Scheduling. Acquisition and Retention Includes Reviews, Text Connect, and Email Marketing. Process Improvements Includes Insurance Verification and Call Intelligence Integrated payment solutions Accelerate A/R collections while strengthening fiscal stability by delivering seamless, low-friction interactions for patients.
Page 16
16 Missed call (2:08 am) Proactive AI text (2:08 am) Staff review (8:00 am) Q2 2026 Every interaction in one platform The power of a persistent interaction: Weave preserves the entire conversation history across channels, ensuring seamless patient care.
Page 17
17 Weave is agentic & proactive Core adoption Q2 2026 AI-powered add-ons: AI Receptionist: Handles scheduling, missed calls, and FAQs. Call Intelligence: Transcribes calls and flags unhappy patients for follow-up. Insurance Eligibility: Automates insurance verification via Robotic Process Automation (RPA). 50% of customer locations use at least one embedded AI solution. >
Page 18
18 Our AI evolutionA deliberate, phased integration of Weave’s AI capabilities across the Weave platform. Q4 2025 Unified Inbox (Launched) Consolidating TrueLark’s text-based AI agent and staff actions into a single contextual view. No more toggling between systems. H2 2026 AI Receptionist General availability. Answering calls 24/7, handling FAQs, booking appointments, and intelligently handing off complex interactions. H2 2026+ Added workflows Skills added to the AI receptionist will include automated payment requests, collection of copays, proactive outreach and scheduling, and pre-treatment deposits within the scheduling flow. Q2 2026
Page 19
19 Financials 19 Q2 2026
Page 20
20 Topline revenue growth at scale ($M) 15.5% Q2—2026 YoY revenue growth 15.5% $50.6 Q2—24 $52.4 Q3—24 $54.2 Q4—24 $55.8 Q1—25 $58.5 Q2—25 $61.3 Q3—25 $63.4 Q4—25 $65.5$67.5 Q1—26 Q2—26 Q2 2026
Page 21
21 71.4% Strong progress on gross margin 71.9% GAAP GM% Q2—24 Non-GAAP GM% 72.0% 72.5% Q3—24 72.1% 72.6% Q4—24 71.6% 72.1% Q1—25 71.7% 72.3% Q2—25 72.3% 73.0% Q3—25 72.7% 73.3% Q4—25 58%Non-GAAP gross margin at IPO (2021) 72.0% 72.6% 72.6% 73.2% Q2—26Q1—26 +30 basis points Q2 2026
Page 22
22 Path to profitability—operating margin GAAP Op margin %Non-GAAP Op margin % Q1—26 Q2—26 3.9% 4.7% 9.2% 6.5% Q2—24 1.9% 18.3% Q3—24 2.7% 12.7% Q4—24 3.3% 13.6% Q1—25 0.1% 16.7% Q2—25 0.1% 17.4% Q3—25 2.7% 14.6% Q4—25 3.6% 3.4% Q2 2026
Page 23
23 Guidance APRIL 2026
Page 24
24 Thankyou 24 Q2 2026 Thank you
Page 25
25 Appendix 25 Q2 2026
Page 26
26 Operating income (loss) reconciliation (non-GAAP) (in thousands) 26 Q2 2026
Page 27
27 Free cash flow reconciliation (non-GAAP) (in thousands) 27 Q2 2026
Page 28
28 Disaggregated revenue and cost of revenue (GAAP) (in thousands) 28APRIL 2026
Page 29
29 Adjusted EBITDA (Non-GAAP) (in thousands) 29 Q2 2026
Page 30
30 Gross margin reconciliation (non-GAAP) (in thousands) 30 Q2 2026